Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D exchange clinic registry

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2639-2645

  Daniels, Mark ^a   Dubose, Stephanie N ^b   Maahs, David M ^c   Beck, Roy W ^b   Fox, Larry A ^d   Gubitosi Klug, Rose ^e   Laffel, Lori M ^f   Miller, Kellee M ^b   Speer, Heather ^a   Tamborlane, William V ^g   Tansey, Michael J ^h  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d NEMOURS CHILDREN S CLINIC   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f JOSLIN DIABETES CENTER   (United States)

^g YALE UNIVERSITY   (United States)

^h UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CHILD; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE REGISTRY; FEMALE; GENDER; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; SCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ALBUMINURIA; BLOOD GLUCOSE; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; RISK FACTORS; YOUNG ADULT;

EID: 84886509566     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2192     Document Type: Article

References (28)

1. American Diabetes Association. Standards of medical care in diabetesd2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
2. Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C. Incidence of endstage renal disease in patients with type 1 diabetes. JAMA 2005;294: 1782-1787
3. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003;26: 1258-1264
4. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J; Linköping Diabetes Complications Study. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes-the Linköping Diabetes Complications Study. Diabetologia 2004;47: 1266-1272
5. Amin R, Widmer B, Dalton RN, Dunger DB. Unchanged incidence of microalbuminuria in children with type 1 diabetes since 1986: a UK based inception cohort. Arch Dis Child 2009;94: 258-262
6. Cho YH, Craig ME, Hing S, et al. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006. Pediatr Diabetes 2011;12: 682-689
7. Marshall SM. Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s? Diabetologia 2012;55: 2301-2306
8. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network. The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012;97: 4383-4389
9. Alleyn CR, Volkening LK, Wolfson J, Rodriguez-Ventura A, Wood JR, Laffel LM. Occurrence of microalbuminuria in young people with type 1 diabetes: importance of age and diabetes duration. Diabet Med 2010;27: 532-537
10. Chiumello G, Bognetti E, Meschi F, Carrà M, Balzano E. Early diagnosis of subclinical complications in insulin dependent diabetic children and adolescents. J Endocrinol Invest 1989;12(Suppl. 3): 101-104
11. Dahlquist G, Rudberg S. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr Scand 1987;76: 795-800
12. Gorman D, Sochett E, Daneman D. The natural history of microalbuminuria in adolescents with type 1 diabetes. J Pediatr 1999;134: 333-337
13. Holl RW, Grabert M, Thon A, Heinze E. Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care 1999;22: 1555-1560
14. Jones CA, Leese GP, Kerr S, et al. Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child 1998;78: 518-523
15. Maahs DM, Snively BM, Bell RA, et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 2007;30: 2593-2598
16. Mathiesen ER, Saurbrey N, Hommel E, Parving HH. Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1986;29: 640-643
17. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al.; Oxford Regional Prospective Study Group. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Diabetes Care 1999;22: 495-502
18. Stone ML, Craig ME, Chan AK, Lee JW, Verge CF, Donaghue KC. Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study. Diabetes Care 2006;29: 2072-2077
19. Twyman S, Rowe D, Mansell P, Schapira D, Betts P, Leatherdale B;Wessex Diabetic Nephropathy Project. Longitudinal study of urinary albumin excretion in young diabetic patientsdWessex Diabetic Nephropathy Project. Diabet Med 2001;18: 402-408
20. Moore TH, Shield JP. Prevalence of abnormal urinary albumin excretion in adolescents and children with insulin dependent diabetes: the MIDAC study. Microalbinuria in Diabetic Adolescents and Children (MIDAC) research group. Arch Dis Child 2000;83: 239-243
21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
22. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125: 177-188
23. Laffel LM, McGill JB, Gans DJ; North American Microalbuminuria Study Group. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995;99: 497-504
24. de Boer IH, Rue TC, Cleary PA, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term renal outcomes of patients with type 1 diabetes mellitus andmicroalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 2011;171: 412-420
25. Vergouwe Y, Soedamah-Muthu SS, Zgibor J, et al. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule.Diabetologia 2010; 53: 254-262
26. Raile K, Galler A, Hofer S, et al. Diabetic nephropathy in 27, 805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007;30: 2523-2528
27. Rademacher E, Mauer M, Jacobs DR Jr, Chavers B, Steinke J, Sinaiko A. Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol 2008;3: 998-1005
28. Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002;39: 445-459